• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Arch Razi Inst . Immunogenicity of Inactivated H5 Avian Influenza Vaccine Used in Commercial Laying Pullet in Tehran Province, Iran

tetano

Editor, Senior Moderator
Arch Razi Inst


. 2024 Jun 30;79(3):499-506.
doi: 10.32592/ARI.2024.79.3.499. eCollection 2024 Jun. Immunogenicity of Inactivated H5 Avian Influenza Vaccine Used in Commercial Laying Pullet in Tehran Province, Iran

S Karami[SUP] 1 [/SUP], V Karimi[SUP] 1 [/SUP], A Barin[SUP] 2 [/SUP], M R Rouigari[SUP] 3 [/SUP], M H Bozorgmehri Fard[SUP] 1 [/SUP]



Affiliations
Abstract

Highly pathogenic avian influenza (HPAI) is a viral disease caused by some H5 and H7 subtypes of influenza virus type A in most species of birds, especially poultry. HPAI viruses are among the most challenging viruses that threaten both human and animal health. Consequently, various strategies, such as the use of vaccines have been proposed to control the disease. After a catastrophic pandemic and the failure of conventional methods (elimination and extermination) in Iran, multiple vaccines have been used to control the disease. This study investigates the immunogenicity of two recombinant inactivated commercial vaccines of H5N1 and H5N3 subtypes in laying pullet flocks in Tehran Province, Iran. From 32 halls in six breeding units of laying pullets, 3,200 sera, and 800 tracheal and cloacal swabs were collected. After collecting the samples, Serum neutralisation (SN) and hemagglutination inhibition (HI) tests were conducted on sera to determine the serum titers of H5 specific antibody obtained from vaccine inoculation in three steps: before, after the first vaccination, and after the second vaccination (booster). The SN and HI tests were carried out by the alpha and beta methods on the pooled samples by the vaccine type (as antigen for HI and SN), and the results were compared. The PCR was performed on the tracheal and cloacal swab samples to possibly detect the HA (H5) virus in the studied flocks. The HI test results showed that both vaccines had a Serum antibody titre above 5 (log[SUB]2[/SUB]) after two vaccination rounds, indicating a desirable immunogenic response. The SN test results also showed a neutralisation index above 10[SUP]4.5[/SUP] for both vaccines, indicating more than 50% reduction in antigenicity of the virus. The PCR results were negative. This study was the first investigation of immunogenicity following two-time vaccination against H5 subtype vaccines in Iranian poultry flocks, indicating suitable antibody titer against the influenza virus in vaccinated flocks.

Keywords: Heamagglutination inhibition; Highly pathogenic avian influenza; PCR; Serum neutralisation; Vaccine.

 
Back
Top Bottom